))
SS24 E02 Report Back From ASCO 2024: What’s the Latest in HR+ MBC?
Manage episode 431638876 series 2977267
SHARE Cancer Support द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री SHARE Cancer Support या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।
Today, we’re bringing you a very special episode created in partnership with SHARE Cancer Support. This is an audio version of our Webinar Report Back from ASCO 2024: Latest Updates on Metastatic Breast Cancer (MBC).
We're excited to present this report from the 2024 ASCO Annual Meeting, highlighting the latest advancements and research in hormone receptor positive (HR+) metastatic breast cancer.
In today's episode, you will hear from Dr. Kevin Kalinsky, a medical oncologist and investigator from Emory. We will dive deep into the findings from the DESTINY-Breast06 trial and the postMONARCH trial. We'll explore the implications of these studies, how they could impact treatment strategies, and what this means for us.
155 एपिसोडस
साझा करें
